{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:44:43Z","timestamp":1792003483129,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To evaluate the choice of antibiotic used for intrapartum Group B Streptococcus (GBS) prophylaxis in pregnant individuals with reported penicillin allergies compared to those without reported penicillin allergies and investigate whether there are associated differences in neonatal outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study Design<\/jats:title>\n                <jats:p>This retrospective cohort study included mother-infant dyads of GBS positive pregnant individuals who labored and delivered newborns\u2009\u2265\u200935 weeks of gestation at a high-volume urban hospital (2005\u20132018). The type of antibiotic administered to the mothers for GBS prophylaxis (beta-lactam prophylaxis defined as penicillin-class drug or cefazolin; alternative prophylaxis defined as vancomycin or clindamycin) was compared between those with a penicillin allergy documented in their medical record versus those who did not. Neonatal outcomes included number of postnatal blood draws, antibiotic administration, neonatal intensive care unit (NICU) admission, bacteremia, and hospital length of stay and were compared between groups. Bivariable and multivariable analyses were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 11,334 mother-infant pairs, 1170 (10.3%) mothers had a penicillin allergy documented in their medical record. Of them, 49 (4.2%) received a penicillin, 259 (22.1%) received cefazolin, 449 (38.4%) received clindamycin, and 413 (35.3%) received vancomycin. Patients with a reported penicillin allergy were significantly more likely to receive alternative GBS prophylaxis compared to those without penicillin allergy (73.7% vs. 0.2%, p\u2009&lt;\u20090.01). Neonates of patients who received alternative GBS prophylaxis were significantly more likely to undergo a postnatal lab draw compared to neonates of patients who received beta-lactam antibiotics (20.8% vs. 17.3%, OR 1.25 (95% CI 1.08\u20131.46)). This significant association persisted after adjusting for potential confounders (aOR 1.23, 95% CI 1.06\u20131.43). There were no other significant differences seen in other newborn outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Pregnant individuals who report a penicillin allergy were more likely to receive alternative antibiotics for GBS prophylaxis compared to those without a penicillin allergy. This was associated with an increased frequency of postnatal blood draws among neonates of mothers with a reported penicillin allergy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Brief summary<\/jats:title>\n                <jats:p>Administration of alternative intrapartum antibiotic prophylaxis with vancomycin or clindamycin is common in individuals with self-reported penicillin allergy, and maternal alternative antibiotic administration may impact neonatal care, particularly via increased lab draws.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-023-05697-0","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T09:04:34Z","timestamp":1685437474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Antibiotic choice for Group B Streptococcus prophylaxis in mothers with reported penicillin allergy and associated newborn outcomes"],"prefix":"10.1186","volume":"23","author":[{"given":"Josephine B.","family":"Snider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena B.","family":"Mithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason H.","family":"Kwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel J.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeun","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"5697_CR1","doi-asserted-by":"crossref","unstructured":"Schrag SJ, Farley MM, Petit S, Reingold A, Weston EJ, Pondo T, Hudson Jain J, Lynfield R. Epidemiology of Invasive Early-Onset neonatal Sepsis, 2005 to 2014. Pediatrics 2016, 138(6).","DOI":"10.1542\/peds.2016-2013"},{"issue":"RR\u201310","key":"5697_CR2","first-page":"1","volume":"59","author":"JR Verani","year":"2010","unstructured":"Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases NCfI, respiratory Diseases CfDC, Prevention: Prevention of perinatal group B streptococcal disease\u2013revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR\u201310):1\u201336.","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"5697_CR3","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1097\/AOG.0000000000003668","volume":"135","author":"Prevention of Group B Streptococcal Early-Onset Disease in Newborns","year":"2020","unstructured":"Prevention of Group B Streptococcal Early-Onset Disease in Newborns. ACOG Committee Opinion, Number 797. Obstet Gynecol. 2020;135(2):e51\u2013e72.","journal-title":"Obstet Gynecol"},{"key":"5697_CR4","doi-asserted-by":"crossref","unstructured":"Puopolo KM, Benitz WE, Zaoutis TE, Committee On F, Newborn CO, Infectious D. Management of neonates born at >\/=35 0\/7 weeks\u2019 Gestation with suspected or proven early-onset bacterial Sepsis. Pediatrics 2018, 142(6).","DOI":"10.1542\/peds.2018-2894"},{"key":"5697_CR5","doi-asserted-by":"crossref","unstructured":"Filkins L, Hauser JR, Robinson-Dunn B, Tibbetts R, Boyanton BL, Revell P. American Society for Microbiology provides 2020 guidelines for detection and identification of Group B Streptococcus. J Clin Microbiol 2020, 59(1).","DOI":"10.1128\/JCM.01230-20"},{"issue":"3","key":"5697_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826","volume":"173","author":"SA Nanduri","year":"2019","unstructured":"Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, Lynfield R, Vagnone PS, Burzlaff K, Spina NL, et al. Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based surveillance. JAMA Pediatr. 2019;173(3):224\u201333.","journal-title":"JAMA Pediatr"},{"issue":"6","key":"5697_CR7","first-page":"25","volume":"41","author":"KM Zangwill","year":"1992","unstructured":"Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ. 1992;41(6):25\u201332.","journal-title":"MMWR CDC Surveill Summ"},{"issue":"28","key":"5697_CR8","first-page":"701","volume":"56","author":"C Centers for Disease","year":"2007","unstructured":"Centers for Disease C, Prevention. Perinatal group B streptococcal disease after universal screening recommendations\u2013United States, 2003\u20132005. MMWR Morb Mortal Wkly Rep. 2007;56(28):701\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"5697_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jama.2018.19283","volume":"321","author":"ES Shenoy","year":"2019","unstructured":"Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy: a review. JAMA. 2019;321(2):188\u201399.","journal-title":"JAMA"},{"issue":"3","key":"5697_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/AOG.0000000000001297","volume":"127","author":"VA Briody","year":"2016","unstructured":"Briody VA, Albright CM, Has P, Hughes BL. Use of Cefazolin for Group B Streptococci Prophylaxis in Women reporting a penicillin Allergy without Anaphylaxis. Obstet Gynecol. 2016;127(3):577\u201383.","journal-title":"Obstet Gynecol"},{"key":"5697_CR11","doi-asserted-by":"publisher","first-page":"917304","DOI":"10.1155\/2013\/917304","volume":"2013","author":"KA Paccione","year":"2013","unstructured":"Paccione KA, Wiesenfeld HC. Guideline adherence for intrapartum group B streptococci prophylaxis in penicillin-allergic patients. Infect Dis Obstet Gynecol. 2013;2013:917304.","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"3","key":"5697_CR12","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1055\/s-0039-1694031","volume":"9","author":"N Desravines","year":"2019","unstructured":"Desravines N, Venkatesh KK, Hopkins A, Waldron J, Grant M, McGuire C, Boggess KA. Intrapartum Group B Streptococcus antibiotic prophylaxis in penicillin allergic pregnant women. AJP Rep. 2019;9(3):e238\u201343.","journal-title":"AJP Rep"},{"issue":"1","key":"5697_CR13","doi-asserted-by":"publisher","first-page":"ofab544","DOI":"10.1093\/ofid\/ofab544","volume":"9","author":"CD Collins","year":"2022","unstructured":"Collins CD, Bookal RS, Malani AN, Leo HL, Shankar T, Scheidel C, West N. Antibiotic use in patients with beta-Lactam Allergies and Pneumonia: impact of an antibiotic side chain-based Cross-Reactivity Chart Combined with enhanced Allergy Assessment. Open Forum Infect Dis. 2022;9(1):ofab544.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"5697_CR14","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jaci.2015.10.026","volume":"137","author":"MN Jeffres","year":"2016","unstructured":"Jeffres MN, Narayanan PP, Shuster JE, Schramm GE. Consequences of avoiding beta-lactams in patients with beta-lactam allergies. J Allergy Clin Immunol. 2016;137(4):1148\u201353.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"5697_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.37765\/ajmc.2020.42832","volume":"26","author":"KG Blumenthal","year":"2020","unstructured":"Blumenthal KG, Oreskovic NM, Fu X, Shebl FM, Mancini CM, Maniates JM, Walensky RP. High-cost, high-need patients: the impact of reported penicillin allergy. Am J Manag Care. 2020;26(4):154\u201361.","journal-title":"Am J Manag Care"},{"key":"5697_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.7812\/TPP\/16-080","volume":"21","author":"SH Desai","year":"2017","unstructured":"Desai SH, Kaplan MS, Chen Q, Macy EM. Morbidity in pregnant women Associated with unverified penicillin allergies, antibiotic use, and Group B Streptococcus Infections. Perm J. 2017;21:16\u2013080.","journal-title":"Perm J"},{"issue":"11","key":"5697_CR17","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/jp.2016.122","volume":"36","author":"CD Wear","year":"2016","unstructured":"Wear CD, Towers CV, Brown MS, Weitz B, Porter S, Wolfe L. Transplacental passage of clindamycin from mother to neonate. J Perinatol. 2016;36(11):960\u20131.","journal-title":"J Perinatol"},{"issue":"8","key":"5697_CR18","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/14767058.2017.1306049","volume":"31","author":"CV Towers","year":"2018","unstructured":"Towers CV, Weitz B. Transplacental passage of vancomycin. J Matern Fetal Neonatal Med. 2018;31(8):1021\u20134.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"5697_CR19","doi-asserted-by":"crossref","unstructured":"Aris IM, Kleinman KP, Belfort MB, Kaimal A, Oken E. A 2017 US reference for Singleton Birth Weight Percentiles using Obstetric estimates of Gestation. Pediatrics 2019, 144(1).","DOI":"10.1542\/peds.2019-0076"},{"issue":"2","key":"5697_CR20","doi-asserted-by":"publisher","first-page":"229e221","DOI":"10.1016\/j.ajog.2015.03.047","volume":"213","author":"RK Edwards","year":"2015","unstructured":"Edwards RK, Tang Y, Raglan GB, Szychowski JM, Schulkin J, Schrag SJ. Survey of American obstetricians regarding group B streptococcus: opinions and practice patterns. Am J Obstet Gynecol. 2015;213(2):229e221\u2013227.","journal-title":"Am J Obstet Gynecol"},{"key":"5697_CR21","unstructured":"Centers for Disease Control and Prevention. : Active bacterial core Surveillance Report, emerging infections Program Network, Group B Streptococcus. 2018."},{"issue":"4","key":"5697_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/bdrc.21116","volume":"105","author":"KM Bendtsen","year":"2015","unstructured":"Bendtsen KM, Fisker L, Hansen AK, Hansen CH, Nielsen DS. The influence of the young microbiome on inflammatory diseases\u2013Lessons from animal studies. Birth Defects Res C Embryo Today. 2015;105(4):278\u201395.","journal-title":"Birth Defects Res C Embryo Today"},{"issue":"1","key":"5697_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40168-017-0313-3","volume":"5","author":"A Nogacka","year":"2017","unstructured":"Nogacka A, Salazar N, Suarez M, Milani C, Arboleya S, Solis G, Fernandez N, Alaez L, Hernandez-Barranco AM, de Reyes-Gavilan L. Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates. Microbiome. 2017;5(1):93.","journal-title":"Microbiome"},{"issue":"6","key":"5697_CR24","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/jac\/dky075","volume":"73","author":"T Gouliouris","year":"2018","unstructured":"Gouliouris T, Warne B, Cartwright EJP, Bedford L, Weerasuriya CK, Raven KE, Brown NM, Torok ME, Limmathurotsakul D, Peacock SJ. Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study. J Antimicrob Chemother. 2018;73(6):1692\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"5697_CR25","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1073\/pnas.122108599","volume":"99","author":"MC Enright","year":"2002","unstructured":"Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A. 2002;99(11):7687\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"5697_CR26","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/jclinpath-2014-202438","volume":"67","author":"M Li","year":"2014","unstructured":"Li M, Krishna MT, Razaq S, Pillay D. A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of \u2018penicillin allergy\u2019 in a UK teaching hospital. J Clin Pathol. 2014;67(12):1088\u201392.","journal-title":"J Clin Pathol"},{"issue":"4","key":"5697_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1365-2222.2003.01638.x","volume":"33","author":"K Sade","year":"2003","unstructured":"Sade K, Holtzer I, Levo Y, Kivity S. The economic burden of antibiotic treatment of penicillin-allergic patients in internal medicine wards of a general tertiary care hospital. Clin Exp Allergy. 2003;33(4):501\u20136.","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"5697_CR28","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/cid\/ciw462","volume":"63","author":"DR MacFadden","year":"2016","unstructured":"MacFadden DR, LaDelfa A, Leen J, Gold WL, Daneman N, Weber E, Al-Busaidi I, Petrescu D, Saltzman I, Devlin M, et al. Impact of reported Beta-lactam allergy on Inpatient Outcomes: a Multicenter prospective cohort study. Clin Infect Dis. 2016;63(7):904\u201310.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5697_CR29","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ajog.2014.01.019","volume":"210","author":"CN Onwuchuruba","year":"2014","unstructured":"Onwuchuruba CN, Towers CV, Howard BC, Hennessy MD, Wolfe L, Brown MS. Transplacental passage of vancomycin from mother to neonate. Am J Obstet Gynecol. 2014;210(4):352. e351-352 e354.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"5697_CR30","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/1471-0528.13601","volume":"123","author":"MB Azad","year":"2016","unstructured":"Azad MB, Konya T, Persaud RR, Guttman DS, Chari RS, Field CJ, Sears MR, Mandhane PJ, Turvey SE, Subbarao P, et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG. 2016;123(6):983\u201393.","journal-title":"BJOG"},{"key":"5697_CR31","doi-asserted-by":"crossref","unstructured":"Cate JJM, Burn M, Kwah J, Liao J, Illuzzi J, Reddy U, Son M. Survey of Obstetric Providers to assess the knowledge and management of a reported penicillin allergy in pregnant women. Am J Perinatol 2022.","DOI":"10.1055\/a-1877-9970"},{"issue":"5","key":"5697_CR32","doi-asserted-by":"publisher","first-page":"100674","DOI":"10.1016\/j.ajogmf.2022.100674","volume":"4","author":"JH Kwah","year":"2022","unstructured":"Kwah JH, Burn MS, Liao J, Cate J, Son M. Outpatient penicillin allergy evaluation during pregnancy and associated clinical outcomes. Am J Obstet Gynecol MFM. 2022;4(5):100674.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"9S","key":"5697_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaip.2020.08.006","volume":"8","author":"AD Broyles","year":"2020","unstructured":"Broyles AD, Banerji A, Barmettler S, Biggs CM, Blumenthal K, Brennan PJ, Breslow RG, Brockow K, Buchheit KM, Cahill KN, et al. Practical Guidance for the evaluation and management of drug hypersensitivity: specific drugs. J Allergy Clin Immunol Pract. 2020;8(9S):16\u2013S116.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"5697_CR34","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/all.13168","volume":"72","author":"KA Sacco","year":"2017","unstructured":"Sacco KA, Bates A, Brigham TJ, Imam JS, Burton MC. Clinical outcomes following inpatient penicillin allergy testing: a systematic review and meta-analysis. Allergy. 2017;72(9):1288\u201396.","journal-title":"Allergy"},{"key":"5697_CR35","doi-asserted-by":"crossref","unstructured":"Committee Opinion No. 797: Prevention of Group B Streptococcal Early-Onset Disease in Newborns: Correction. Obstet Gynecol. 2020, 135(4):978\u2013979.","DOI":"10.1097\/AOG.0000000000003824"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-05697-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-023-05697-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-05697-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T09:11:59Z","timestamp":1685437919000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-023-05697-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5697"],"URL":"https:\/\/doi.org\/10.1186\/s12884-023-05697-0","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"16 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this study was obtained from the Northwestern University Institutional Review Board with a waiver of informed consent prior to its initiation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"400"}}